IP Library Granted Patent US 8,185,176
Granted Patent B2
US 8,185,176 · App. 11/912,878 · Granted May 22, 2012

Method and apparatus for vasculature visualization with applications in neurosurgery and neurology

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,185,176
App. No.
11/912,878
Granted
May 22, 2012
Kind
B2
Abstract

The invention provides methods and systems for neurovascular imaging ( 150 ).

Claims (85)

1. A computer implemented method of intra-operatively confirming the removal of at least one vessel comprising an arteriovenous malformation in a subject, comprising:

a. administering a fluorescent dye to a recipient subject;

b. applying a sufficient amount of energy to a vessel in the subject such that the fluorescent dye fluoresces;

c. detecting pixel data in a detection area to be imaged;

d. transmitting the pixel data to a processor;

e. obtaining a fluorescing image of the vessel;

f. observing the fluorescing image to identify a location of an arteriovenous malformation;

g. surgically removing the vessel including the arteriovenous malformation;

h. intraoperatively confirming the removal of the vessel including the arteriovenous malformation by observing the fluorescing image to determine if a fluorescent signal stops at a point of removal of the vessel, wherein a lack of a fluorescent signal downstream of the point of removal indicates the arteriovenous malformation has been removed; and

i. calculating on the processor a relative maximum fluorescent intensity in an area of fluorescence, the area of fluorescence indicated by a number of pixels associated with the fluorescing dye in a pre treatment image and a post treatment image corresponding to the detection area, wherein a fewer number of pixels and less fluorescent intensity at the detector area indicates a removal of the arteriovenous malformation, and a greater number of pixels and greater fluorescent intensity at the detection area indicates a non-removal of the arteriovenous malformation.

2. The method of claim 1 , wherein the recipient subject is an animal.

3. The method of claim 1 , wherein the animal is a human.

4. The method of claim 1 , wherein the fluorescent dye is a tricarbocyanine dye or an analog thereof.

5. The method of claim 4 , wherein the tricarbocyanine dye is indocyanine green.

6. The method of claim 1 , wherein the fluorescent dye comprises a mixture or combination of multiple fluorescent dyes or analogs thereof.

7. The method of claim 1 , wherein the dye is administered intravenously.

8. The method of claim 1 , wherein the dye is administered by catheter or cannula.

9. The method of claim 1 , wherein the dye is administered as a bolus injection.

10. The method of claim 1 , wherein the dye is administered less than an hour before confirming removal of the arteriovenous malformation.

11. The method of claim 1 , wherein the dye is administered more than 30 seconds confirming removal of the arteriovenous malformation.

12. The method of claim 1 , wherein the energy is light energy.

13. The method of claim 12 , wherein the light energy is provided by a laser.

14. The method of claim 13 , wherein the laser power output is about 2.5 watts.

15. The method of claim 14 , wherein the laser power output lasts for about 30 seconds.

16. The method of claim 14 , wherein the output is a continuous wave.

17. The method of claim 12 , wherein the light energy is provided by an incandescent light and a filter.

18. The method of claim 12 , wherein the wavelength of the light energy is in the infra-red spectrum.

19. The method of claim 12 , wherein the wavelength of the light energy is about 805 nanometers.

20. The method of claim 1 , wherein the image is obtained by a camera.

21. The method of claim 20 , wherein the camera is a charge coupled device.

22. The method of claim 20 , wherein the camera is a video recorder.

23. The method of claim 1 , wherein the vessel is a blood vessel.

24. The method of claim 1 , wherein the vessel is an artery.

25. The method of claim 1 , wherein the vessel is a vein.

26. The method of claim 1 , wherein the vessel is a nidus associated with AVM.

27. The method of claim 1 , wherein the vessel is surgically exposed.

28. A computer implemented method of intra-operatively locating at least one vessel comprising an arteriovenous malformation in a subject, comprising:

a. administering a fluorescent dye to a recipient subject;

b. applying a sufficient amount of energy to at least one vessel to the subject such that the fluorescent dye fluoresces;

c. detecting pixel datain a detection area to be imaged;

d. transmitting the pixel data to a processor;

e. obtaining a fluorescing image of the at least one vessel;

f. intraoperatively locating a suspect vessel of said at least one vessel, the suspect vessel having an arteriovenous malformation;

g. observing the image to determine if the fluorescent signal leaks from the suspected vessel, wherein a leak of a fluorescent signal from the suspected vessel indicates an arteriovenous malformation; and

h. calculating on the processor a relative maximum fluorescent intensity in an area of fluorescence, the area of fluorescence indicated by a number of pixels associated with the fluorescing dye in a pre treatment image and a post treatment image corresponding to the detection area, wherein a fewer number of pixels and less fluorescent intensity at the detector area indicates a removal of the arteriovenous malformation, and a greater number of pixels and greater fluorescent intensity at the detection area indicates a non-removal of the arteriovenous malformation.

29. The method of claim 28 , wherein the recipient subject is an animal.

30. The method of claim 29 , wherein the animal is a human.

31. The method of claim 28 , wherein the fluorescent dye is a tricarbocyanine dye or an analog thereof.

32. The method of claim 31 , wherein the fluorescent dye comprises a mixture or combination of a first fluorescent dye or analogs thereof and a second fluorescent dye or analog thereof.

33. The method of claim 31 , wherein the tricarbocyanine dye is indocyanine green.

34. The method of claim 28 , wherein the dye is administered intravenously.

35. The method of claim 28 , wherein the dye is administered as a bolus injection.

36. The method of claim 28 , wherein the dye is administered by catheter or annula.

37. The method of claim 28 , wherein the dye is administered less than an hour before confirming removal of the arteriovenous malformation.

38. The method of claim 28 , wherein the dye is administered more than 30 seconds confirming removal of the arteriovenous malformation.

39. The method of claim 28 , wherein the energy is light energy.

40. The method of claim 39 , wherein the light energy is provided by a laser.

41. The method of claim 40 , wherein the laser power output is about 2.5 watts.

42. The method of claim 41 , wherein output is a continuous wave.

43. The method of claim 40 , wherein the laser power output lasts for about 30 seconds.

44. The method of claim 39 , wherein the light energy is provided by an incandescent light and a filter.

45. The method of claim 39 , wherein the wavelength of the light energy is in the infra-red spectrum.

46. The method of claim 39 , wherein the wavelength of the light energy is about 805 nanometers.

47. The method of claim 28 , wherein the image is obtained by a camera.

48. The method of claim 47 , wherein the camera is a charge coupled device.

49. The method of claim 47 , wherein the camera is a video recorder.

50. The method of claim 28 , wherein the vessel is a blood vessel.

51. The method of claim 28 , wherein the vessel is an artery.

52. The method of claim 28 , wherein the vessel is a vein.

53. The method of claim 28 , wherein the vessel is a nidus associated with AVM.

54. The method of claim 28 , wherein the vessel is surgically exposed.

55. A portable system comprising:

a) a device for administering fluorescent dye to a subject;

b) an energy source capable of emitting two laser beams of sufficient energy such that the fluorescent dye fluoresces;

c) an imaging head for imaging at least one vessel; and

d) a processor coupled to perform the method of claim 1 or claim 28 .

56. The system of claim 55 , comprising a field of view having a first dimension of about 0.5 to 1.5 inches and a second dimension of about 0.5 to about 1.5 inches.

57. The system of claim 55 , wherein the first and second dimension are approximately 1 inch.

58. The system of claim 55 , wherein the system has an irradiance in the range of about 15-25 mW/cm 2 .

59. The system of claim 55 , wherein the two laser beams converge at a common focal point.

60. The system of claim 55 , wherein the two laser beams comprise green light.

61. The system of claim 55 , wherein the two laser beams comprise radiation in the infrared spectrum.

62. The system of claim 55 , said system comprising a second energy source capable of emitting sufficient energy to excite a second fluorescent dye such that said second fluorescent dye fluoresces.

63. The system of claim 55 , wherein the imaging head is contained in an endoscope.

64. The system of claim 55 , wherein the imaging head is contained in a surgical microscope.

Assignments (19)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2023
From: STRYKER EUROPEAN OPERATIONS LIMITED
To: STRYKER CORPORATION
Reel/Frame 066140/0647 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052860 FRAME: 0900. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 12/31/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 056426/0585 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 044910 FRAME: 0507. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES INC.
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 056425/0530 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053823 FRAME: 0445. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/29/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 056426/0496 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0597. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 056426/0352 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICAITON NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053318 FRAME: 0612. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 056425/0731 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0548. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/30/2017. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 056425/0616 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 052873/0597 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 052860/0900 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 052873/0548 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 053318/0612 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 053823/0445 →
MERGER AND CHANGE OF NAME Recorded Dec 19, 2017
From: NOVADAQ TECHNOLOGIES INC.; STRYKER CANADA OPERATIONS ULC
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 044910/0507 →
RELEASE OF SECURITY INTEREST Recorded Sep 8, 2017
From: MIDCAP FINANCIAL TRUST
To: NOVADAQ TECHNOLOGIES INC.; NOVADAQ CORP.
Reel/Frame 043788/0799 →
RELEASE OF SECURITY INTEREST Recorded Sep 8, 2017
From: MIDCAP FUNDING IV TRUST (AS SUCCESSOR AGENT TO MIDCAP FINANCIAL TRUST)
To: NOVADAQ TECHNOLOGIES INC.; NOVADAQ CORP.
Reel/Frame 043786/0344 →
SECURITY AGREEMENT (TERM) Recorded Jan 9, 2017
From: NOVADAQ TECHNOLOGIES; NOVADAQ CORP.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 041306/0189 →
SECURITY AGREEMENT (REVOLVING) Recorded Jan 9, 2017
From: NOVADAQ TECHNOLOGIES; NOVADAQ CORP.
To: MIDCAP FINANCIAL TRUST, AS AGENT
Reel/Frame 041306/0172 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2013
From: MANGAT, GURPREET; BRZOZOWSKI, LUKASZ; CROFT, RICHARD L.
To: NOVADAQ TECHNOLOGIES, INC.
Reel/Frame 030747/0930 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 26, 2013
From: MANGAT, GURPREET; BRZOZOWSKI, LUKASZ
To: NOVADAQ TECHNOLOGIES INC.
Reel/Frame 030691/0698 →